Petmed Express, Inc. Reports Earnings Results for the Third Quarter Ended December 31, 2019
January 21, 2020 at 06:30 pm IST
Share
PetMed Express, Inc. announced earnings results for the third quarter ended December 31, 2019. For the third quarter, the company announced sales was USD 59.915 million compared to USD 60.068 million a year ago. Operating income was USD 7.932 million compared to USD 9.413 million a year ago. Net income was USD 6.840 million compared to USD 7.787 million a year ago. Basic earnings per share was USD 0.34 compared to USD 0.38 a year ago. For the nine months, sales was USD 209.839 million compared to USD 218.854 million a year ago. Operating income was USD 22.464 million compared to USD 38.373 million a year ago. Net income was USD 18.848 million compared to USD 31.121 million a year ago. Basic earnings per share was USD 0.94 compared to USD 1.52 a year ago.
PetMed Express, Inc., doing business as PetMeds, is a direct-to-consumer pet pharmacy. The Company is an online provider of prescription and non-prescription medications, food, supplements, and supplies and has veterinary and pet insurance service partnerships for dogs, cats, and horses. It markets and sells directly to consumers through their Websites, toll-free numbers, and employer benefit partnerships. Its product line contains over 15,000 SKUs of pet medications, health products, foods, and supplies. The Company offers various pet supplies, including beds, crates, stairs and other pet supplies. Its products include Prescription Medications (Rx), Non-Prescription Medications (OTC) and supplies, Pet Foods, Private Label and Holistic Wellness Services. Rx includes heartworm and flea and ticks preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.
PETMED EXPRESS, INC. 
